Adnexus Therapeutics Incorporated
A biotechnology company focused on developing new class of therapeutic compounds.
Adnexus Therapeutics is a leader in the discovery and early development of protein molecules, we call Adnectins. Adnectins are designed to either block or stimulate the action of specific proteins to fight diseases across a broad range of therapeutic areas including oncology and immunology. Their proprietary technology for engineering these proteins creates an opportunity to rapidly generate compounds for further study in a broad range of disease types.